US Stocks: Kodiak Sciences shares soar 68% after eye drug succeeds in late-stage study by ET Markets | March 26, 2026 9:05 pm | Indian Stocks, Market, News Shares of Kodiak Sciences surged 68.6% to their highest in more than four years on Thursday after the drug developer’s experimental drug met the main goal in a late-stage study in patients with diabetes-related eye damage.
